Page 11 - Clinical Laboratory Automation How To Achieve An Automated Utopia For Your Lab Selectscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Clinical laboratory automation how to achieve an automated utopia for your lab selectscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Clinical Laboratory Automation How To Achieve An Automated Utopia For Your Lab Selectscience Today - Breaking & Trending Today

Me-two drug? Viking mid-stage trial wins with GLP-1/GIP bid

The enticing prospect – and proven worth – of dually agonizing the glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors gained more evidence in a big way from Viking Therapeutics Inc. with VK-2735 in a phase II weight loss study. Shares of San Diego-based Viking Therapeutics Inc. (NASDAQ:VKTX) closed Feb. 27 at $85.05, up $46.57, or 121%, as investors learned that the drug achieved the primary and all secondary endpoints in the phase II study called Venture, with significant body-weight drops at all doses compared to placebo. ....

San Viking Therapeutics Inc , Therapeutics Inc , Viking Therapeutics , San Diego Based Viking Therapeutics , Viking Therapeutics Inc , Vk 2735 , Glp 1 , Endocrine Metabolic , Glucagon Like Peptide 1 , Glucose Dependent Insulinotropic Polypeptide Receptors ,

BEYOND CHEMO AND CLINICAL TRIALS

SocietyBreast cancer, a pervasive global health concern, is increasingly making its presence felt among young women in the subcontinent. While traditionally perceived as a disease affecting older age groups, recent trends point to a disturbing rise. ....

New Delhi , Sri Lanka , Sara Danial , World Health Organization , National Institute Of Cancer Prevention , South Asian , South Asia , Indian Journal , National Institute , Cancer Prevention ,

Is Alzheimer's the same as dementia? A brain expert explains

A breakthrough new drug to treat brain disease is always welcome news. Last summer, the performance of the drugs donanemab and lecanemab in clinical trials. ....

United Kingdom , Alois Alzheimer , David Cox , Regulatory Agency , Alzheimer Research United Kingdom , Research United Kingdom ,